Physician profile
Stephen R Goll
NPI 1689645426
$154,314.27
in general payments reported to CMS, 2019-2025
7 companies · $19K in 2025
The $19K reported for 2025 was more than what 78% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $21K · 2021: $24K · 2022: $16K · 2023: $31K · 2024: $17K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $68K · Food and Beverage: $26.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $67,715.49 |
| Food and Beverage | $26.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osseus Fusion Systems, LLC | $151,259.06 | 2019-2025 | |
| Spine Wave, INC. | $1,465.28 | 2019-2020 | |
| Integrity Implants INC. | $762.77 | 2019 | |
| Depuy Synthes Sales INC. | $751.06 | 2019-2022 | |
| Medtronic, INC. | $36.18 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $26.39 | 2023 | |
| Stimwave Technologies Incorporated | $13.53 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Goll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.